Clinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCR
2020 · EBioMedicine · 181 citations
https://doi.org/10.1016/j.ebiom.2020.102960
L
Lina Yi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
89
Papers
3.3K
Citations
29
h-index
50
i10-index
Lina Yi is an academic researcher from Nanchang University. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Viral Infections and Immunology Research & Animal Disease Management and Epidemiology. The author has an h-index of 29, co-authored 76 publications.
ORCID: 0000-0003-1122-6999Papers by this author
worksEvaluation of QuantiFERON-TB Gold Plus for Detection of Mycobacterium tuberculosis infection in Japan
2016 · Scientific Reports · 85 citations
https://doi.org/10.1038/srep30617
Epidemiology, evolution and transmission of human metapneumovirus in Guangzhou China, 2013–2017
2019 · Scientific Reports · 55 citations
https://doi.org/10.1038/s41598-019-50340-8
Seroepidemiology of human enterovirus71 and coxsackievirusA16 among children in Guangdong province, China
2013 · BMC Infectious Diseases · 37 citations
https://doi.org/10.1186/1471-2334-13-322
The Emergence of Coxsackievirus A16 Subgenotype B1c: A Key Driver of the Hand, Foot, and Mouth Disease Epidemic in Guangdong, China
2025 · Viruses · 5 citations
https://doi.org/10.3390/v17020219
USP13: A therapeutic target for combating tumorigenesis and antitumor therapy resistance
2025 · International Journal of Biological Macromolecules · 3 citations
https://doi.org/10.1016/j.ijbiomac.2025.140608
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat